Rezultati pretraživanja
  1. prije 14 sati

    After three mega-mergers ( /CELG, /AGN, /SHPG ), we are now seeing two mega-split today Investment bankers always win...

  2. 4. velj

    Tues (2/4/20) earnings +/- % from OR 30-min high, Up/Avg Gain of today’s thirteen 30-min bars, G/L % in final 30-Min & Trading range %: (Min $5 & Vol 750K, Opt Min Vol 250 in any strike):

  3. Takeda executives say coronavirus has no impact on Chinese unit inherited from Shire

  4. 4. velj

    Today marks the 7th week for the last set of patients on the FT218 Sleepon trial. 6 more weeks for completion of treatment period. FT218 targets Xyrem”s 1.7B market!! Ph3 results 4 weeks after completion of trial period!!! AVDL undervalued, 3-4X potential

  5. 4. velj

    earnings AH likely to see Qs on how they will catch up in . Admit to being behind in HemA HemB but focus on nextgen AAV with redosing. Biggest focus with lagging and progressing. M&A in C20 to catchup?

  6. 2. velj
    Odgovor korisniku/ci

    I really think makes breakthroughs by leaps and bounds leaving in dust, while Adi vigorously jerks off to every paycheck he gets which he didn't earn. At the same time Adi worshippers vigorously jerk off to images of Adi jerking off. Sometimes bending over too!

  7. 30. sij
    Odgovor korisnicima

    Tagrisso has little to no activity towards exon 20. shit the bed. should soon too. Also shouldn’t work... hypoxia activated? That’s going to be so toxic.

  8. 29. sij

    R&D day graphic and collab tracking.

    Prikaži ovu nit
  9. 29. sij

    Tale of 2 partners. is rolling. is reeling

    Prikaži ovu nit
  10. 29. sij

    Phase 1 A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors…NCT02699749. Estimated Primary Completion Date - 02/2020

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.